A practical, risk-based strategy for evaluating and managing metabolic dysfunction-associated steatosis and steatohepatitis (MASLD/MASH) highlights the need for integrated care in patients with obesity and metabolic comorbidities.
A practical, risk-based strategy for evaluating and managing metabolic dysfunction-associated steatosis and steatohepatitis (MASLD/MASH) highlights the need for integrated care in patients with obesity and metabolic comorbidities.
A study presented at the American College of Gastroenterology, reveals that primary sclerosing cholangitis independently increases the risk of colorectal cancer.
A study presented at the American College of Gastroenterology, reveals that primary sclerosing cholangitis independently increases the risk of colorectal cancer.
Research on racial and economic disparities underscores the urgent need for targeted interventions to promote early detection and equitable health care access.
Research on racial and economic disparities underscores the urgent need for targeted interventions to promote early detection and equitable health care access.
The proposed adjusted postcolonoscopy colorectal cancer rate provides a more accurate and reproducible standardized benchmark while minimizing heterogeneity, the investigators concluded.
The proposed adjusted postcolonoscopy colorectal cancer rate provides a more accurate and reproducible standardized benchmark while minimizing heterogeneity, the investigators concluded.
Compared with lean patients with IBD and MASLD, overweight/obese patients with IBD and MASLD had higher levels of insulin resistance and smoking history, the study found.
Compared with lean patients with IBD and MASLD, overweight/obese patients with IBD and MASLD had higher levels of insulin resistance and smoking history, the study found.
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
